In agreement with the present findings, metabolic control by V600EBRAF could be envisaged on the basis of its signaling through the MEK and ERK kinases and activation of MYC or HIF-1α, both of which are major determinants of cancer metabolism [37,48]. The gene discussed is MAP2K7; the disease is cancer.